Clinical Trial Update: Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study comparing the pharmacokinetics of LEP-ETU (liposome-entrapped paclitaxel) with Taxol in patients with advanced cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• LEP-ETU (liposome-entrapped paclitaxel)
• Taxol (paclitaxel)

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Neoplasm | Phase 1 | Status: COMPLETED